News
Walmart (WMT) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Walmart (WMT) reports results for the quarter ended July 2026. While this widely-known consensus outlook is
Deere (DE) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Deere (DE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended July 2026. This widely-known consensus outlook is
Here's What Key Metrics Tell Us About Bit Digital (BTBT) Q2 Earnings
For the quarter ended June 2026, Bit Digital, Inc. (BTBT) reported revenue of $32.11 million, up 25% over the same period last year. EPS came in at -$0.06, compared to -$0.03 in the year-ago
Advance Auto Parts (AAP) Earnings Expected to Grow: Should You Buy?
The market expects Advance Auto Parts (AAP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus
Bet on Neocloud Providers With This New ETF
GPU-as-a-Service (GPUaaS) allows businesses and developers to access powerful GPUs through the cloud without buying and maintaining costly hardware. The model provides flexible, scalable computing
Can Keytruda Sustain Merck's Growth in the Second Half of 2026?
Merck’s MRK strong foothold in the oncology space is backed by its biggest revenue driver, Keytruda. The blockbuster PD-L1 inhibitor alone accounts for more than 55% of the company’s total
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs
Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and
Coherent Q4 Earnings Call Highlights Faster AI Optics Capacity Ramp
Coherent Corp. COHR used its fiscal fourth-quarter 2026 earnings call to frame fiscal 2027 around a faster production ramp, AI optics demand and new revenue streams. CEO Jim Anderson said quarterly
Anterix's Q1 Earnings Call Focuses on Spectrum Optionality
Anterix Inc. ATEX used its first-quarter fiscal 2027 earnings call to emphasize rising demand for licensed low-band spectrum and a widening set of monetization paths. CEO and President Scott Lang
5 ETFs to Benefit From Cooling Inflation in the Near Term
The annual inflation rate in the United States slowed for a second successive month to 3.4% in July 2026, from 3.5% in June, in line with expectations. The impact of the energy shock caused by the
WYFI Q2 Earnings Call Focuses on NC-1 Ramp and Cloud Expansion
WhiteFiber, Inc. WYFI used its second-quarter 2026 earnings call to frame NC-1 as the first proof point in a repeatable data center model, while emphasizing longer-duration cloud contracts and
NBIS Q2 Earnings Call Puts 2027 Capacity and Pricing in Focus
Nebius Group N.V. NBIS used its Q2 2026 earnings call to emphasize capacity expansion, pricing discipline and its decision not to pre-sell all planned 2027 capacity.
Management reaffirmed its 2026
CBRS Q2 Earnings Call Focuses on Capacity for 2027 Growth
Cerebras Systems Inc. CBRS used its second-quarter 2026 earnings call to emphasize the capacity build needed to support revenue expansion next year. CEO Andrew Feldman framed 2026 as a foundation
LQDA Q2 Earnings Call Highlights YUTREPIA and $1B 2027 Revenue Path
Liquidia Corporation LQDA used its Q2 2026 earnings call to reinforce a forward message centered on YUTREPIA adoption, commercial expansion and a path to more than $1 billion in net revenue in 2027.
Cisco Q4 Earnings Call Centers on AI Networking Supercycle
Cisco Systems, Inc. CSCO used its fiscal fourth-quarter 2026 call to frame AI as the catalyst for a broader networking refresh. Chairman and CEO Chuck Robbins pointed to demand across hyperscalers
SE Q2 Earnings Miss Estimates as Costs Rise, Revenues Beat & Grew Y/Y
Sea Limited’s SE adjusted earnings were 86 cents per share in the second quarter of 2026, missing the Zacks Consensus Estimate by 14%. On a reported basis, earnings per share rose 7.7% year over
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know
Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $13.58, gaining 30% over the past four weeks, but there could be plenty of upside left in the stock if short-term
Wall Street Analysts Think DoubleDown Interactive (DDI) Could Surge 45.96%: Read This Before Placing a Bet
DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) closed the last trading session at $12.25, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if
Wall Street Analysts Believe Central Garden (CENTA) Could Rally 28.12%: Here's is How to Trade
Central Garden (CENTA) closed the last trading session at $38.83, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Predict a 26.35% Upside in Figs (FIGS): Here's What You Should Know
Shares of Figs (FIGS) have gained 45.1% over the past four weeks to close the last trading session at $14.42, but there could still be a solid upside left in the stock if short-term price targets of
How Much Upside is Left in Curaleaf Holdings, Inc. (CURLF)? Wall Street Analysts Think 40.63%
Shares of Curaleaf Holdings, Inc. (CURLF) have gained 1.8% over the past four weeks to close the last trading session at $9.87, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 26.07% Upside in Mistras (MG): Can the Stock Really Move This High?
Shares of Mistras (MG) have gained 8.7% over the past four weeks to close the last trading session at $17.45, but there could still be a solid upside left in the stock if short-term price targets of
How Much Upside is Left in Rogers Corp. (ROG)? Wall Street Analysts Think 25.08%
Shares of Rogers Corp. (ROG) have gained 0.1% over the past four weeks to close the last trading session at $138.58, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
Shattuck Labs, Inc. (STTK) closed the last trading session at $7.49, gaining 10.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect?
Immunic (IMUX) closed the last trading session at $15.93, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street


